Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis

End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease

(2016) Arun J. Sanyal et al.   GASTROENTEROLOGY

Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis

(2016) Arun J. Sanyal et al.   GASTROENTEROLOGY

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood

(2016) Martin L. Decaris et al.   HEPATOLOGY

MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice

(2016) Parambir S. Dulai et al.   JOURNAL OF HEPATOLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop

(2015) Arun J. Sanyal et al.   HEPATOLOGY

Data-driven desirability function to measure patients’ disease progression in a longitudinal study

(2015) Hsiu-Wen Chen et al.   JOURNAL OF APPLIED STATISTICS

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

(2015) Brent A Neuschwander-Tetri et al.   LANCET

Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy

(2015) Tong-Hong Wang et al.   Scientific Reports

qFibrosis: A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients

(2014) Shuoyu Xu et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic Fatty Liver Disease: What the Pathologist Can Tell the Clinician

(2012) Elizabeth M. Brunt   DIGESTIVE DISEASES

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

(2012) Roberta D'Ambrosio et al.   HEPATOLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

(2011) Michael R. Charlton et al.   GASTROENTEROLOGY

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

(2011) Zobair M. Younossi et al.   HEPATOLOGY

Use of desirability functions to evaluate health status in patients with cirrhosis

(2010) Chris Gennings et al.   JOURNAL OF HEPATOLOGY

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease

(2008) Valerio Nobili et al.   GASTROENTEROLOGY